We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$4.82B
AUM Growth
-$1.08B
Cap. Flow
-$892M
Cap. Flow %
-18.51%
Top 10 Hldgs %
24.39%
Holding
2,488
New
830
Increased
522
Reduced
528
Closed
596

Sector Composition

Rank Sector Weight
1 Financials 12.22%
2 Technology 9.56%
3 Industrials 9%
4 Consumer Discretionary 6.63%
5 Healthcare 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNW icon
1776
Genworth Financial
GNW
$3.85B
$174K ﹤0.01%
+39,426
New +$164K
SXC icon
1777
SunCoke Energy
SXC
$779M
$174K ﹤0.01%
30,903
+3,305
+12% +$23.8K
VRAY
1778
DELISTED
ViewRay, Inc.
VRAY
$174K ﹤0.01%
+59,992
New +$355K
FET icon
1779
Forum Energy Technologies
FET
$593M
$172K ﹤0.01%
5,545
+3,064
+123% +$126K
FCX icon
1780
Freeport-McMoran
FCX
$88.6B
$171K ﹤0.01%
+17,884
New +$184K
BFX
1781
DELISTED
BowFlex Inc.
BFX
$171K ﹤0.01%
127,000
-4,500
-3% -$7.06K
VIRT icon
1782
Virtu Financial
VIRT
$5.11B
$170K ﹤0.01%
+10,377
New +$208K
RNAC icon
1783
Cartesian Therapeutics
RNAC
$225M
$166K ﹤0.01%
3,153
-1,977
-39% -$105K
ACOR
1784
DELISTED
Acorda Therapeutics
ACOR
$163K ﹤0.01%
+473
New +$257K
SONO icon
1785
Sonos
SONO
$2B
$161K ﹤0.01%
+11,981
New +$150K
NEOS
1786
DELISTED
Neos Therapeutics, Inc
NEOS
$159K ﹤0.01%
107,524
-105,676
-50% -$171K
PGEN icon
1787
Precigen
PGEN
$1.97B
$157K ﹤0.01%
+27,409
New +$186K
FSTX
1788
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$157K ﹤0.01%
11,182
-4,393
-28% -$72.4K
IVR icon
1789
Invesco Mortgage Capital
IVR
$769M
$154K ﹤0.01%
+1,006
New +$160K
SPOK icon
1790
Spok Holdings
SPOK
$228M
$154K ﹤0.01%
+12,935
New +$167K
AQN icon
1791
Algonquin Power & Utilities
AQN
$4.68B
$152K ﹤0.01%
11,100
-9,752
-47% -$126K
AGFS
1792
DELISTED
AgroFresh Solutions Inc
AGFS
$151K ﹤0.01%
57,503
-84,488
-60% -$147K
FBP icon
1793
First Bancorp
FBP
$4.47B
$150K ﹤0.01%
+14,983
New +$152K
NWSA icon
1794
News Corp Class A
NWSA
$15.3B
$146K ﹤0.01%
+10,500
New +$143K
CSLT
1795
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$146K ﹤0.01%
+103,700
New +$207K
BRSP
1796
BrightSpire Capital
BRSP
$683M
$145K ﹤0.01%
10,020
-2,780
-22% -$40.5K
PBR.A icon
1797
Petrobras Class A
PBR.A
$104B
$145K ﹤0.01%
11,058
-8,510
-43% -$114K
VALE icon
1798
Vale
VALE
$62.6B
$144K ﹤0.01%
+12,528
New +$152K
NCMI icon
1799
National CineMedia
NCMI
$371M
$143K ﹤0.01%
1,749
-3,427
-66% -$256K
OR icon
1800
OR Royalties Inc
OR
$5.52B
$141K ﹤0.01%
+15,209
New +$179K

Similar funds

Paloma Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Paloma Partners held 2,488 positions worth $4.82B, down 18% from $5.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Paloma Partners withdrew a net $892M in Q3 2019, closing 596 positions and reducing 528 holdings. Its most notable exit was State Street Communication Services Select Sector SPDR ETF, an estimated $93.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.

Against the trend, Paloma Partners opened a new position in State Street Financial Select Sector SPDR ETF worth $235M.

  • Paloma Partners's largest Q3 2019 buy was State Street Financial Select Sector SPDR ETF: 8,375,441 shares worth $235M.
  • Paloma Partners added most to State Street Technology Select Sector SPDR ETF in Q3 2019, an estimated $69.7M increase.
  • Paloma Partners's biggest Q3 2019 reduction was JPMorgan Chase, cutting an estimated $74M.
  • Paloma Partners fully exited State Street Communication Services Select Sector SPDR ETF in Q3 2019, selling an estimated $93.6M.
  • Paloma Partners's ten largest holdings make up 24% of its $4.82B portfolio in Q3 2019.
  • Paloma Partners opened 830 new positions and closed 596 in Q3 2019.
  • Paloma Partners's portfolio value fell 18% quarter-over-quarter to $4.82B.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.